Company Valuation: Guided Therapeutics, Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2020 2021 2022 2023 2024 2025
Market Cap 1 3.928 7.91 14.58 8.305 9.77 46.52
Change - 101.4% 84.3% -43.03% 17.63% 376.2%
Enterprise Value (EV) 1 8.151 10.17 14.53 9.772 11.54 49.4
Change - 24.73% 42.91% -32.74% 18.1% 328.05%
P/E -7.5x -3.19x -1.96x -2.09x -3x -12.7x
PBR -0.29x -0.64x -2.44x -1.22x -1.24x -6.1x
PEG - -0x 0.1x 0x 0.1x 0.9x
Capitalization / Revenue 38.5x 97.7x 1,121x 84.7x 1,396x 60.7x
EV / Revenue 79.9x 126x 1,118x 99.7x 1,649x 64.4x
EV / EBITDA -7.91x -4.31x -4.36x -2.83x -5.5x -20.9x
EV / EBIT -7.75x -4.3x -4.36x -2.83x -5.47x -20.8x
EV / FCF -3.22x -4.61x -12.6x -9.89x -17.4x -83.4x
FCF Yield -31% -21.7% -7.93% -10.1% -5.73% -1.2%
Dividend per Share 2 - - - - - -
Rate of return - - - - - -
EPS 2 -0.04 -0.1817 -0.153 -0.0735 -0.05 -0.0427
Distribution rate - - - - - -
Net sales 1 0.102 0.081 0.013 0.098 0.007 0.767
EBITDA 1 -1.031 -2.361 -3.329 -3.448 -2.099 -2.362
EBIT 1 -1.052 -2.362 -3.333 -3.457 -2.108 -2.372
Net income 1 -0.279 -2.07 -4.341 -3.489 -2.417 -3.196
Net Debt 1 4.223 2.256 -0.05 1.467 1.771 2.876
Reference price 2 0.2999 0.5802 0.3000 0.1535 0.1500 0.5400
Nbr of stocks (in thousands) 13,096 13,634 48,596 54,105 65,131 86,154
Announcement Date 4/7/21 3/30/22 3/30/23 3/28/24 3/31/25 3/31/26
1USD in Million2USD
Estimates


P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 23.94M
33.55x5.86x22.46x0.27% 250B
37.86x6.77x21.47x0.63% 158B
43.91x11.62x25.64x-.--% 143B
16.61x3.4x11.09x-.--% 63.65B
34.1x6.82x21.58x-.--% 49.74B
33.66x6.66x22.6x0.59% 48.71B
18.61x2.27x11.47x2.71% 47.94B
75.9x7.23x22.05x-.--% 42.59B
54.59x8.79x31.04x-.--% 40.77B
Average 38.75x 6.60x 21.04x 0.47% 84.4B
Weighted average by Cap. 37.18x 6.93x 21.68x 0.39%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA


  1. Stock Market
  2. Stocks
  3. GTHP Stock
  4. Valuation Guided Therapeutics, Inc.